Meeder Asset Management Inc Maravai Lifesciences Holdings, Inc. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $28,655 - $36,354	2,206 New	2,206 $30,000
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $4,037 - $5,952	-196 Reduced 36.7%	338 $9,000
Q2 2022 Aug 08, 2022	BUY	$26.05 - $37.48 $26 - $37	1 Added 0.19%	534 $15,000
Q1 2022 May 10, 2022	SELL	$24.46 - $40.92 $47,256 - $79,057	-1,932 Reduced 78.38%	533 $19,000
Q4 2021 Feb 11, 2022	BUY	$35.0 - $45.94 $86,275 - $113,242	2,465 New	2,465 $103,000

227

135M

339K

148K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $919M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.